# Chapter 14 evidence audit

- Audit model: `validate-medical-chapter` v1
- Audit date: 2026-07-19
- Pre-revision score: **7/10**
- Post-revision score: **10/10**
- Current major guidance checked: robotic-vs-laparoscopic RCT review 2023, ESGO cervical guideline 2023, haptic-platform update 2025

| Q# | Verification question | Source-grounded answer | Chapter finding before revision | Verdict before revision | Correction | Sources |
|---:|---|---|---|---|---|---|
| 1 | Does pneumoperitoneum affect venous return, ventilation, CO2, and organ perfusion? | Yes; magnitude depends on pressure, position, cardiopulmonary reserve, and duration. | Correct. | SUPPORTED | None. | Schwartz 11e |
| 2 | Are trocar, bowel/vascular, thermal, embolic, and pressure-related injuries valid MIS risks? | Yes; prevention and early recognition are critical. | Correct. | SUPPORTED | Retained. | Schwartz 11e |
| 3 | Is conversion to open surgery a safety decision rather than failure? | Yes; uncontrolled bleeding, unclear anatomy, injury, instability, or oncologic compromise justify conversion. | Correct. | SUPPORTED | None. | Schwartz 11e |
| 4 | Are robotic outcomes universally superior to laparoscopic outcomes? | No. Across RCTs, mortality and most complication/LOS outcomes are often similar; time and cost are commonly higher. | Correctly warned against universal superiority. | SUPPORTED | Strengthened with systematic review. | [RCT review](https://pubmed.ncbi.nlm.nih.gov/37442833/) |
| 5 | Is laparoscopy necessarily limited to two-dimensional vision? | No; 3D laparoscopic systems are available, although traditional 2D remains common. | Comparison table defined laparoscopy as 2D. | INCORRECT | Changed to 2D or 3D and retained instrument limitations. | [RCT review](https://pubmed.ncbi.nlm.nih.gov/37442833/) |
| 6 | Do all current surgical robots lack haptic feedback? | No. Most installed legacy systems have limited force feedback, but newer platforms include integrated haptic/force feedback. | Stated absent haptics as a platform-wide limitation. | NEEDS_NUANCE | Made the limitation platform/version specific. | [Haptic update](https://pubmed.ncbi.nlm.nih.gov/40031533/) |
| 7 | Is minimally invasive radical hysterectomy standard for early cervical cancer? | No. LACC showed inferior disease-free and overall survival; current guidelines favor open radical surgery in appropriate early disease. | Correctly highlighted the exception. | SUPPORTED | Retained. | [LACC](https://pubmed.ncbi.nlm.nih.gov/30380365/), [ESGO](https://pubmed.ncbi.nlm.nih.gov/37127326/) |
| 8 | Did ROLARR demonstrate a significant conversion benefit? | No; its primary conversion outcome was not significantly improved, although later evidence and subgroups continue to evolve. | Correct. | SUPPORTED | Retained. | [ROLARR](https://pubmed.ncbi.nlm.nih.gov/29067426/) |
| 9 | Can one robotic-vs-laparoscopic comparison be generalized across procedures? | No; advantages and tradeoffs are procedure-, platform-, and experience-specific. | Gave the right general warning but relied mainly on one rectal trial. | NEEDS_NUANCE | Added cross-procedure RCT synthesis and procedure-specific rule. | [RCT review](https://pubmed.ncbi.nlm.nih.gov/37442833/) |
| 10 | Are NOTES and SILS routine replacements for multiport laparoscopy? | No; applications remain selective, with access/closure, instrumentation, learning, and evidence limitations. | Correct. | SUPPORTED | Retained. | [NOTES review](https://pubmed.ncbi.nlm.nih.gov/40589380/) |

## Re-audit conclusion

After revision, all ten questions are `SUPPORTED`. Platform characteristics are now version specific, and evidence is interpreted by procedure rather than by technology label.

Robotic systems and indications evolve quickly. A 10/10 audit score is a quality threshold, not a substitute for current device data, cancer guideline, and institutional credentialing.
